Biogen (NASDAQ:BIIB) Earns Peer Perform Rating from Analysts at Wolfe Research
Research analysts at Wolfe Research initiated coverage on shares of Biogen (NASDAQ:BIIB – Get Free Report) in a report issued ...
Managed Healthcare Executive22h
SMA Drugs Jockey for Position in the Marketplace
Roche’s Evrysdi (risdiplam) is the market leader among the drugs for spinal muscular atrophy (SMA). Biogen’s Spinraza ...
bovnews19h
Why Did Wolfe Research Give Biogen Inc (BIIB) Stock Peer Perform Rating?
On Friday, Biogen Inc (BIIB) stock saw a decline, ending the day at $159.99 which represents a decrease of $-4.90 or -2.97% from the prior close of $164.89. The stock opened at $165.46 and touched a ...
Social Security's Silver Lining Has Been Ripped Away for a Second Consecutive Year
While Social Security's 2025 COLA announcement offers superficial promise, the lack of a treasured silver lining will quickly ...
Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo
Detailed price information for Royalty Pharma Plc Cl A (RPRX-Q) from The Globe and Mail including charting and trades.
Athersys (NASDAQ:ATHX) Now Covered by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a report released on Thursday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock ...
BBC21h
World
The Ukrainian president also said his country "must do everything" to ensure the war ends next year. The president-elect's picks for defence secretary, attorney general and health secretary are ...
The New York Times20h
New York Times - Top Stories
Under the Chandelier at Mar-a-Lago, Trump Makes Picks at Breakneck Speed President-elect Trump is more contemptuous than ever of Washington expertise and determined to hire people based on loyalty ...